from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3440c/-

LFCtreatmentdescriptionclass of inhibitor

0.435

Amikacinug/mL Amikacintranslation

0.894

Cap5-10ug/mL Capreomycintranslation

1.252

Rox10-50 ug/mL Roxithromycintranslation

0.207

SM2-5 ug/mL Streptomycintranslation

0.865

Tet5-10 ug/mL Tetracyclinetranslation

0.009

Rif0.2-5ug/mL Rifampicintranscription

0.360

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.993

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.390

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.265

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.493

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.638

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.089

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.187

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.090

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.764

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.506

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.054

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.588

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.323

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.751

KCN5-20 ug/mL Potassium cyaniderespiration

0.197

NaN30.2-2 mM Sodium aziderespiration

-0.386

Nigericin50 uM Nigericinrespiration

-0.474

TRC10-150 ug/mL Triclosanrespiration

-0.246

TRZ10-25 ug/mL Thioridazinerespiration

2.294

Valinomycin0.5-10 uM Valinomycinrespiration

-0.608

ZnSO42 mM ZnSO4respiration

0.771

menadione6-10 ug/mL Menadionerespiration

-0.573

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.003

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.263

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.238

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.860

NRP_1Non-replicating persistence stage 1dosRassociated

0.121

Amp0.2mg/mL AmpicillincellWall

-0.109

Cephalexin20-100 ug/mL CephalexincellWall

0.112

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.131

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.197

EMB10-20 ug/mL EthambutolcellWall

-0.454

Eta12-40 ug/mL EthionamidecellWall

-0.623

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.601

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.709

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.226

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.198

BZA0.12 mg/mL BenzamidearomaticAmides

0.566

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.348

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.398

H2O24 mM hydrogen peroxideDNAdamaging

0.277

Levo10 ug/mL LevofloxacinDNAdamaging

0.245

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.242

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.574

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.064

UVUV-irradiationDNAdamaging

-1.150

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.657

Antimycin12.5-50 ug/mL Antimycin A?

-0.354

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.029

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.796

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.843

PA8240.2-2 ug/mL PA-824?

0.081

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.399

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.747

Verapamil50 uM Verapamil?

-0.092

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.042

methoxatin10-20 ug/mL Methoxatin?